Bortenat 3.5 mg Injection
$46,92
$35,38
Bortenat 3.5 mg Injection is an essential therapeutic option in the fight against cancer, specifically targeting multiple myeloma and mantle cell lymphoma, both of which are aggressive forms of malignancies affecting the blood and immune system. This innovative medication operates by inhibiting specific proteins that play a crucial role in the survival and proliferation of cancer cells, leading to their eventual destruction. As a part of a comprehensive treatment plan, Bortenat may be used in conjunction with other therapies to enhance efficacy. It is important to be aware of potential side effects, including fatigue, nausea, and an increased risk of infections, necessitating close monitoring by healthcare professionals. Patients should inform their doctors of any existing health conditions or medications to avoid interactions. Bortenat 3.5 mg Injection is typically administered under the supervision of a qualified healthcare provider, ensuring both safety and optimal results. By understanding its mechanism and usage, patients can be better prepared for their treatment journey. If you or a loved one is facing a diagnosis of multiple myeloma or mantle cell lymphoma, discussing Bortenat with your oncologist could be a pivotal step toward effective management of the disease.
數量
Active Pharmaceutical Ingredient
Uses
• Bortenat 3 5 mg injection is primarily used in the treatment of multiple myeloma, a cancer that affects plasma cells in the bone marrow. These abnormal plasma cells disrupt the production of normal blood cells, leading to various health complications. Patients may experience symptoms such as bone pain, fatigue, and recurrent infections. Administering Bortenat helps manage these symptoms and improve overall quality of life.
• Another significant application of Bortenat 3 5 mg injection is in the treatment of mantle cell lymphoma, a rare and aggressive form of non-Hodgkin lymphoma. This type of cancer originates from B cells, which play a crucial role in the immune system. Patients with mantle cell lymphoma often present with symptoms like enlarged lymph nodes, weight loss, and fever. Bortenat aids in targeting the cancerous cells, thereby contributing to better patient outcomes.
• Bortenat 3 5 mg injection can be utilized as part of a combination therapy regimen for patients with relapsed or refractory multiple myeloma. In such cases, the treatment aims to enhance the efficacy of other therapeutic agents. By incorporating Bortenat into the treatment plan, healthcare providers can improve response rates and help manage disease progression. This makes it a valuable option in the therapeutic landscape of multiple myeloma.
• Additionally, Bortenat 3 5 mg injection is beneficial for patients who have not responded adequately to previous treatments for mantle cell lymphoma. It provides a new approach to combat the disease when conventional therapies fail. By effectively targeting malignant cells, Bortenat can lead to significant improvements in patient conditions. This use underscores its importance in managing challenging cancer cases.
Benefits
Bortenat 3.5 mg Injection contains the active substance bortezomib, also called ‘proteome inhibitor. Proteasomes play an important role in controlling cell function and growth. By interfering with their function, it can kill cancer cells. Bortenat 3.5 mg is used to treat multiple myeloma (a cancer of the bone marrow) and mantle cell lymphoma (a type of cancer affecting the lymph nodes) in people 18 years or older. It may be used alone or together with other medicines.
Side Effects
Like all medications, Bortenat 3.5 mg Vial can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Burning feeling of skin
• Stomach Pain
• Insomnia
• Dehydration
• Pneumonia
• High fever
Common Side Effects
• High Blood Pressure
• Tiredness
• Cough
• Chest Tightness
• Feet Swelling
How To Use
Bortenat 3.5 mg is administered intravenously or subcutaneously at a hospital or clinic setting by a doctor or nurse. Your doctor will decide the right time to take the injection, so always follow your doctor's advice. The dose and how often you take it depend on what you are taking it for. You might be prescribed certain other medicine as a part of your treatment. You should take this medicine for as long as it is prescribed for you.
Safety Advice
• Alcohol: Consumption of alcohol is not recommended while using Bortenat 3.5 mg Vial. Alcohol may increase or decrease the effectiveness of the medicine and also increase the risk of side effects. It is the best advice for you: before consuming alcohol, you can talk with a doctor or pharmacist, and they will tell you if consumption of alcohol is safe or not.
• Kidney: Bortenat 3.5 mg Vial should be used with caution in patients with kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Bortezomib Injection 3.5 mg and report any unusual symptoms or changes in kidney function to their doctor. Your doctor may need to adjust the dose in such kidney disease patients.
• Breastfeeding: It is unknown whether Bortenat Injection is excreted in human milk. If you are breastfeeding and taking this medicine. It is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Bortenat 3.5 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Bortezomib Injection 3.5 mg and report any unusual symptoms or changes in liver function to their doctor. Your doctor may need to adjust the dose in such liver disease patients.
• Pregnancy: Animal reproduction studies have not been conducted with Bortenat Injection. Bortenat 3.5 mg Injection is generally considered unsafe during pregnancy. If you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Bortenat 3.5 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Bortenat 3.5 mg Injection will not affect your ability to drive or operate machinery. In case you experience any side effects while taking Bortezomib Injection 3.5 mg, such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.